vs
KESTRA MEDICAL TECHNOLOGIES, LTD.(KMTS)与Orchid Island Capital, Inc.(ORC)财务数据对比。点击上方公司名可切换其他公司
Orchid Island Capital, Inc.的季度营收约是KESTRA MEDICAL TECHNOLOGIES, LTD.的1.7倍($38.5M vs $22.6M),Orchid Island Capital, Inc.净利率更高(268.7% vs -145.3%,领先414.0%)
Kestra Medical Technologies(KMTS)是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业,核心产品覆盖介入心脏病学与结构性心脏病治疗领域,市场覆盖北美、欧洲及亚太重点区域,服务全球医疗机构与患者。
Orchid Island Capital是一家总部设在美国的专业金融企业,以房地产投资信托的形式开展运营,主要投资机构类及非机构类住宅抵押贷款支持证券,深耕美国固定收益市场,致力于为投资者创造稳定的经风险调整后的长期回报。
KMTS vs ORC — 直观对比
营收规模更大
ORC
是对方的1.7倍
$22.6M
净利率更高
ORC
高出414.0%
-145.3%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $22.6M | $38.5M |
| 净利润 | $-32.8M | $103.4M |
| 毛利率 | 50.6% | — |
| 营业利润率 | -140.7% | — |
| 净利率 | -145.3% | 268.7% |
| 营收同比 | — | 372.6% |
| 净利润同比 | — | 1764.9% |
| 每股收益(稀释后) | $-0.64 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
KMTS
ORC
| Q4 25 | $22.6M | $38.5M | ||
| Q3 25 | $19.4M | $26.9M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | — | $19.7M | ||
| Q3 24 | — | $340.0K | ||
| Q2 24 | — | $-697.0K | ||
| Q1 24 | — | $-2.5M | ||
| Q4 22 | — | $2.4M |
净利润
KMTS
ORC
| Q4 25 | $-32.8M | $103.4M | ||
| Q3 25 | $-25.8M | $72.1M | ||
| Q2 25 | — | $-33.6M | ||
| Q1 25 | — | $17.1M | ||
| Q3 24 | — | $17.3M | ||
| Q2 24 | — | $-5.0M | ||
| Q1 24 | — | $19.8M | ||
| Q4 22 | — | — |
毛利率
KMTS
ORC
| Q4 25 | 50.6% | — | ||
| Q3 25 | 45.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — |
营业利润率
KMTS
ORC
| Q4 25 | -140.7% | — | ||
| Q3 25 | -149.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — |
净利率
KMTS
ORC
| Q4 25 | -145.3% | 268.7% | ||
| Q3 25 | -133.3% | 267.8% | ||
| Q2 25 | — | -145.0% | ||
| Q1 25 | — | 86.9% | ||
| Q3 24 | — | 5094.1% | ||
| Q2 24 | — | 714.3% | ||
| Q1 24 | — | -794.2% | ||
| Q4 22 | — | — |
每股收益(稀释后)
KMTS
ORC
| Q4 25 | $-0.64 | — | ||
| Q3 25 | $-0.50 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $175.4M | $665.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $164.1M | $1.4B |
| 总资产 | $246.7M | $11.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
KMTS
ORC
| Q4 25 | $175.4M | $665.9M | ||
| Q3 25 | $201.2M | $583.9M | ||
| Q2 25 | — | $440.8M | ||
| Q1 25 | — | $396.4M | ||
| Q3 24 | — | $322.1M | ||
| Q2 24 | — | $241.0M | ||
| Q1 24 | — | $190.4M | ||
| Q4 22 | — | $205.7M |
股东权益
KMTS
ORC
| Q4 25 | $164.1M | $1.4B | ||
| Q3 25 | $184.2M | $1.1B | ||
| Q2 25 | — | $912.0M | ||
| Q1 25 | — | $855.9M | ||
| Q3 24 | — | $656.0M | ||
| Q2 24 | — | $555.9M | ||
| Q1 24 | — | $481.6M | ||
| Q4 22 | — | $438.8M |
总资产
KMTS
ORC
| Q4 25 | $246.7M | $11.7B | ||
| Q3 25 | $266.3M | $9.1B | ||
| Q2 25 | — | $7.6B | ||
| Q1 25 | — | $7.3B | ||
| Q3 24 | — | $5.9B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | — | $4.2B | ||
| Q4 22 | — | $3.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-18.3M | $120.4M |
| 自由现金流经营现金流 - 资本支出 | $-25.6M | — |
| 自由现金流率自由现金流/营收 | -113.5% | — |
| 资本支出强度资本支出/营收 | 32.2% | — |
| 现金转化率经营现金流/净利润 | — | 1.16× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
KMTS
ORC
| Q4 25 | $-18.3M | $120.4M | ||
| Q3 25 | $-26.3M | $28.0M | ||
| Q2 25 | — | $18.4M | ||
| Q1 25 | — | $25.8M | ||
| Q3 24 | — | $-14.8M | ||
| Q2 24 | — | $19.3M | ||
| Q1 24 | — | $45.0M | ||
| Q4 22 | — | $289.4M |
自由现金流
KMTS
ORC
| Q4 25 | $-25.6M | — | ||
| Q3 25 | $-34.4M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — |
自由现金流率
KMTS
ORC
| Q4 25 | -113.5% | — | ||
| Q3 25 | -177.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — |
资本支出强度
KMTS
ORC
| Q4 25 | 32.2% | — | ||
| Q3 25 | 42.2% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — |
现金转化率
KMTS
ORC
| Q4 25 | — | 1.16× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.51× | ||
| Q3 24 | — | -0.86× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 2.28× | ||
| Q4 22 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图